MacroGenics, Inc.
MGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $106 | $76 | $80 | $204 |
| - Cash | $80 | $131 | $146 | $183 |
| + Debt | $37 | $108 | $37 | $37 |
| Enterprise Value | $63 | $53 | -$28 | $58 |
| Revenue | $73 | $22 | $13 | $18 |
| % Growth | 227.5% | 68.6% | -25.6% | – |
| Gross Profit | $59 | $13 | $8 | $12 |
| % Margin | 81.6% | 60% | 59.1% | 69% |
| EBITDA | $22 | -$33 | -$39 | -$12 |
| % Margin | 30.1% | -150.3% | -297% | -70.2% |
| Net Income | $17 | -$36 | -$41 | -$15 |
| % Margin | 23.1% | -163% | -311.1% | -87% |
| EPS Diluted | 0.27 | -0.57 | -0.65 | -0.25 |
| % Growth | 147.4% | 12.3% | -160% | – |
| Operating Cash Flow | -$30 | -$47 | -$47 | -$38 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$31 | -$48 | -$47 | -$39 |